Pharmaceutical/biotech - Articles - Page 12

U.K. Fights EpiPen Shortage by Extending Injector Expiry Dates

October 30, 2018

As a shortage of epinephrine pens continues to grip the U.K., authorities have agreed to extend the expiration date on a second injector to help ease the situation.

Patients ‘May Need to Stockpile Own Drugs’ If No-Deal Brexit Looms

October 29, 2018

The Guardian

If the U.K. leaves the EU with no deal, it could be “catastrophic” for medicine supplies — and necessitate emergency powers, the pharmaceuticals industry says.

Opinion

Drug Companies, Not 'Middlemen', Are Responsible for High Drug Prices

October 25, 2018

Forbes

As pharmaceutical companies have faced more heat for their pricing practices, they’ve found someone else to blame: “middlemen” who extract discounts from drugmakers.

Q&A

IoT's Impact: What the Tech Promises in Logistics, Food, Pharma and Warehousing

October 22, 2018

SupplyChainBrain

The internet of things is revolutionizing supply chains, but the value of some actions that connected devices can take may be questionable.

Think Tank

How a ‘Value-Based’ Approach Is Transforming Healthcare Services and Supply Chains

October 22, 2018

Robert J. Bowman, SupplyChainBrain

Certain shifts in business strategy seem so shockingly obvious in retrospect that you have to wonder why they weren’t common practice all along.

Think Tank

Additive Manufacturing and the Supply Chain: Opportunities and Risks

October 17, 2018

Ilan Solel

Many supply-chain headaches can be alleviated with 3-D printing, but there are some perils attached to the benefits.

Think Tank

The Science of ‘Fingerprinting’ Products in the Supply Chain

October 15, 2018

Robert J. Bowman, SupplyChainBrain

The term “forensic science” conjures up images of police dramas and crime investigations. But it turns out to have a strong connection to global supply chains, too.

Nafta by Any Other Name Is Just Fine With Corporate America

October 4, 2018

Bloomberg

The sky isn’t falling. That’s the message coming from Corporate America after President Trump reached a deal to revise the North American Free Trade Agreement.

Here’s What’s in the New Nafta

There’s a lot to digest in the new trade agreement that the United States, Mexico and Canada finalized in deadline-beating fashion on Sunday, starting with a name change.

October 2, 2018

The New York Times

There’s a lot to digest in the new trade agreement that the United States, Mexico and Canada, starting with a name change.

Blockchain Hype May Finally Turn Into Reality in Pharmaceuticals

Blockchain believers have delivered little more than hype, mostly failing to get it deployed outside the cryptocurrency space where the technology was developed. But a little-noticed U.S. law could change that, bringing the ledger system to the pharmaceutical business.

September 26, 2018

Bloomberg

Blockchain believers have delivered little more than hype, mostly failing to get it deployed outside the cryptocurrency space where the technology was developed. But a little-noticed U.S. law could change that, bringing the ledger system to the pharmaceutical business.